ISSN 2564-7784 | E-ISSN 2564-7040
Original Article
The Effectiveness of Percutaneous Drainage on the Treatment of Mesh-Induced Seroma
1 Department of Radiology, Karabük University Training and Research Hospital, Karabük, Turkey  
Eur J Ther ; : -
DOI: 10.5152/EurJTher.2018.699
Key Words: Percutaneous treatment, mesh-related seroma, salvage the mesh

Objective: To investigate the effectiveness of percutaneous treatment of mesh-related seroma to salvage the mesh. 


Methods: Between October 2015-December 2017, 4 patients (3 female, 1 male) with repaired ventral hernia, mean 68.5±22 years old (range, 61-83 years), underwent percutaneous drainage to the treatment of peri-mesh seroma were evaluated, retrospectively. In all patients, ultrasound (US) was used to diagnose seroma and guidance imaging method during percutaneous procedures. General purpose pigtail-percutaneous drainage sets were used in all patients. Ethanol (96%) was used for sclerotherapy and fibrinolytic agent was used to destroy septa in multilocular collections. Laboratory investigations and co-morbidities were evaluated in hospital data service, retrospectively. Mainly clinical success rates were evaluated and technical success rates, procedure-related morbidity and mortality were also evaluated.


Results: Totally, 11 percutaneous drainage sessions (median, 2; range 1-6) were performed in 4 patients. The mean volume of fluid collections was 807.3±3006 cc (median, 291 cc; range, 114-3120 cc). There was no significant difference between mesh sizes. Technical success rates were 100%.  There was no procedure-related morbidity and mortality. The mean of recurrence time of the peri-mesh seroma was 3.5±11 months (median, 2 months; range, 1-12 months).  In all patients, during the follow-ups, the seroma was accumulated repetitively.


Conclusion: Percutaneous treatment is an effective management option to salvage the mesh in patients with mesh-related seroma who are poor surgical candidates or whose mesh cannot be removed.

Key Words
AVES | Copyright © 2019 European Journal of Therapeutics | Latest Update: 28.05.2019